Aside from AATD patients [28], it has also been used to measure AAT concentration, along with other molecules, as a biomarker of disease severity in ulcerative colitis [29], long-term recovery of chronic disorder of consciousness [30], bladder cancer diagnosis signature [31], or inflammatory profile in chronic obstructive pulmonary disease [32]. This evidence concerns the gene SERPINA1 and urinary bladder cancer.